Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Multiple Myeloma × Patient Comfort × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Thymoma 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Multidisciplinary Collaborative 1 Lymphoma 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Malignant Solid Neoplasm 1

Interventions

Cyclophosphamide 17 fludarabine phosphate 11 Peripheral Blood Stem Cell Transplantation 10 Cyclosporine 10 fludarabine 9 Whole-Body Irradiation 9 Exercise 8 Dexamethasone 8 Blood Specimen Collection 8 Antilymphocyte Serum 8 Mycophenolic Acid 7 Standard of Care 6 Radiotherapy 6 Melphalan 6 Filgrastim 6 Busulfan 6 Acupuncture Therapy 6 Palliative Care 5 Educational Status 5 Behavior Therapy 5 Therapeutics 4 Surveys and Questionnaires 4 Stem Cell Transplantation 4 Psychiatric Rehabilitation 4 Practice Guidelines as Topic 4 Interviews as Topic 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 thymoglobulin 3 pomalidomide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed

51 enrolled 8 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡